Science ❯ Medical Science ❯ Vaccine Development ❯ Clinical Trials

Safety and Efficacy

FDA Approves LP.8.1 COVID Boosters, Limits Routine Use to Seniors and High-Risk Patients

Uncertainty over CDC guidance now clouds insurance coverage.